Late congenital syphilitic chorioretinitis
ICD-10 A50.32 is a billable code used to indicate a diagnosis of late congenital syphilitic chorioretinitis.
Late congenital syphilitic chorioretinitis is a severe ocular manifestation of congenital syphilis, which occurs when the Treponema pallidum bacterium is transmitted from an infected mother to her fetus during pregnancy. This condition typically manifests in infants who were not treated for syphilis during gestation. Chorioretinitis refers to the inflammation of the choroid and retina, leading to potential vision impairment or blindness. Clinically, it may present with symptoms such as photophobia, blurred vision, and strabismus. Diagnosis is often made through a combination of clinical examination, serological testing for syphilis, and imaging studies. Treatment involves managing the underlying syphilis infection with appropriate antibiotics, typically penicillin, and addressing any ocular complications that arise. Early detection and intervention are crucial to prevent long-term visual impairment. The condition underscores the importance of prenatal screening for syphilis and the need for timely treatment to mitigate risks to the fetus.
Detailed ocular examination findings, including visual acuity and any imaging results.
Infants presenting with vision problems, strabismus, or photophobia.
Need for comprehensive documentation of ocular health and any interventions performed.
Prenatal screening results for syphilis, maternal treatment history, and infant follow-up.
Pregnant women with a history of syphilis or at risk for STIs.
Importance of documenting maternal treatment to prevent congenital transmission.
Used during follow-up visits for infants diagnosed with A50.32.
Complete ocular examination findings and treatment plan.
Ophthalmologists should document all findings related to congenital syphilitic chorioretinitis.
Accurate coding of A50.32 is crucial for proper treatment planning, epidemiological tracking of congenital syphilis, and ensuring appropriate reimbursement for healthcare providers.
